PDF下载 ( 1780 KB)
Application of a modified diagnostic scale in diagnosis of acute drug-induced liver injury
-
摘要:
目的建立一种急性药物性肝损伤（DILI）的改良诊断量表并在临床验证使用。方法收集2011年1月-2015年12月在首都医科大学附属北京佑安医院治疗的82例急性DILI患者,其中DILI组52例,非DILI组30例。在Roussel Uclaf因果关系评价表（RUCAM）基础上,参考DDW-J量表,新增"中药单药或成药有肝损伤的报道"、"嗜酸性粒细胞计数"和"基于CCK-8法的药物淋巴细胞刺激试验"3个参数,建立一种改良诊断量表。对2组患者的每种可疑药物分别进行RUCAM和改良诊断量表评分,验证新量表对DILI诊断的敏感度和特异度。计数资料组间比较采用χ2检验。结果 DILI组共75个可疑药物;非DILI组共41个可疑药物。与RUCAM相比,改良诊断量表可将DILI组中评估为"高度可能"和"很可能"的诊断敏感度由74.7%提高至94.7%（χ2=11.554,P=0.001）;而非DILI组只有2个药物（4.9%）的评估结果由"可能"变为"很可能",其余药物均维持"可能"、"不太可能"和"可除外",诊断特异度由100%降至95.1%（χ
Abstract:Objective To investigate the application of a modified diagnostic scale in the diagnosis of acute drug-induced liver injury (DILI) .Methods A total of 82 patients with acute DILI who were treated in Beijing You An Hospital, Capital Medical University from January 2011 to December 2015 were enrolled, among whom 52 were enrolled in DILI group and 30 were enrolled in non-DILI group.On the basis of Roussel Uclaf Causality Assessment Method (RUCAM) scale and with reference to Digestive Disease Week Japan scale, three parameters, i.e., “report of liver injury induced by single Chinese materia medica or Chinese patent medicine”, “eosinophil count”, and “drug lymphocyte stimulation test based on Cell Counting Kit-8”, were added to establish a modified diagnostic scale.The RUCAM scale and the modified diagnostic scale were used to evaluate each suspected drug to verify the sensitivity and specificity of this new scale in the diagnosis of DILI.The chi-square test was used for comparison of categorical data between groups.Results There were 75 suspected drugs in the DILI group and 41 suspected drugs in the non-DILI group.Compared with the RUCAM scale, the modified diagnostic scale increased the number of drugs evaluated as “highly probable” and “probable” from 74.7% to 94.7% (χ2=11.554, P=0.001) in the DILI group.In the non-DILI group, only 2 drugs (4.9%) were changed from“possible”to“probable”, and the other drugs were maintained as “possible”, “unlikely”, or“excluded”;the specificity of diagnosis was reduced from 100% to 95.1% (χ2=0.512, P=0.474) .Conclusion Compared with the RUCAM scale, this modified diagnostic scale has an increased sensitivity and a reduced specificity of diagnosis and needs to be further validated in clinical practice.
-
Key words:
- drug-induced liver injury /
- diagnostic scale
-
[1]FAN ZP, LIANG S, NIE W, et al.The application of a novel drug lymphocyte stimulation test using Cell Counting Kit-8 assay in diagnosis of drug-induced liver injury[J].J Clin Hepatol, 2016, 32 (8) :1562-1565. (in Chinese) 范作鹏, 梁珊, 聂巍, 等.基于细胞计数试剂盒8的药物淋巴细胞刺激试验在急性药物性肝损伤诊断中的应用[J].临床肝胆病杂志, 2016, 32 (8) :1562-1565. [2]DANAN G, BENICHOU C.Causality assessment of adverse reactions to drugs---I.A novel method based on the conclusions of international consensus meetings:application to drug-induced liver injuries[J].J Clin Epidemiol, 1993, 46 (11) :1323-1330. [3]WATANABE M, SHIBUYA A.Validity study of a new diagnostic scale for drug-induced liver injury in Japan-comparison with two previous scales[J].Hepatol Res, 2004, 30 (3) :148-154. [4]CHALASANI NP, HAYASHI PH, BONKOVSKY HL, et al.ACGClinical Guideline:the diagnosis and management of idiosyncratic drug-induced liver injury[J].Am J Gastroenterol, 2014, 109 (7) :950-966. [5]Drug-induced Liver Disease Study Group, Chinese Society of Hepatology, Chinese Medical Association.Guidelines for the management of drug-induced liver injury[J].J Clin Hepatol, 2015, 31 (11) :1752-1769. (in Chinese) 中华医学会肝病学分会药物性肝病学组.药物性肝损伤诊治指南[J].临床肝胆病杂志, 2015, 31 (11) :1752-1769. [6] HAO KY, YU YC, HE CL.RUCAM sacle-based diagnosis, clinical features and prognosis of 140 cases of drug-induced liver injury[J].Chin J Hepatol, 2014, 22 (12) :938-941. (in Chinese) 郝坤艳, 于乐成, 何长伦.基于Roussel uclaf因果关系评估量表的药物性肝损伤140例诊治分析[J].中华肝脏病杂志, 2014, 22 (12) :938-941. [7] NARANJO CA, BUSTO U, SELLERS EM, et al.A method for estimating the probability of adverse drug reactions[J].Clin Pharmacol Ther, 1981, 30 (2) :239-245. [8]MARIA VA, VICTORINO RM.Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis[J].Hepatology, 1997, 26 (3) :664-669. [9]TAJIRI K, SHIMIZU Y.Practical guidelines for diagnosis and early management of drug-induced liver injury[J].World J Gastroenterol, 2008, 14 (44) :6774-6785. [10]JIANG WH, SHI XH, LIANG WF, et al.Clinical analysis of 124patients with drug-induced hepatitis[J].Chin J Med, 2012, 47 (6) :58-59. (in Chinese) 江文华, 石晓红, 梁伟峰, 等.药物性肝炎124例临床分析[J].中国医刊, 2012, 47 (6) :58-59. 期刊类型引用(5)
1. 董旭，刘亚允，朱彤，徐爱静，薛建亚，梁雪松. 基于HBV感染自然病程的慢性乙型肝炎患者外周血白细胞介素-35表达水平及与病毒载量和转氨酶的相关性. 新发传染病电子杂志. 2023(02): 8-12 . 
百度学术2. 李彧，李连香，奚逢瑜，薛敬东，叶苗青，杨跃青，党珊，张鸿，段降龙，高瑛. 白细胞介素-35对肝细胞癌患者CD4~+CD25~+CD127~(dim/-)调节性T细胞的调控作用. 实用癌症杂志. 2023(08): 1239-1244 . 百度学术3. 杨晓飞，连建奇，张野. IL-35在HBV感染所致疾病中的调控作用和相关机制. 临床肝胆病杂志. 2022(05): 1148-1151 . 
本站查看4. 廖艳霞，何德宁，陈卫国. 白介素-35在血浆透析滤过治疗重型肝炎前后的变化及其意义. 中国当代医药. 2021(12): 65-67+70 . 百度学术5. 金磊，朱佳佳，杨亚东. 血清白细胞介素-35、T细胞亚群与脓毒症病情严重程度及预后的关系. 中国医药导报. 2021(25): 84-88 . 百度学术其他类型引用(1)
-
百度学术
下载:
